Trial of PBF-509 and PDR001 in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)

Clinical trial NCT02403193 · COMPLETED

Trial details

NCT number: NCT02403193
Sponsor: Palobiofarma SL
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer (NSCLC)

Start date: 2015-10-01
Primary completion: 2021-10-01
Enrollment: 92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.